Douglas S. Ingram - 16 Dec 2025 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Doug Ingram
Issuer symbol
ARWR
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
18 Dec 2025, 18:39:56 UTC
Previous filing
09 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
INGRAM DOUGLAS S Director 177 EAST COLORADO BLVD, SUITE 700, PASADENA /s/Doug Ingram 18 Dec 2025 0001190644

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +7,819 +20% $0.000000 46,215 16 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such date.